BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 6364223)

  • 1. B cell neoplasms: correlation of recent developments with the biology of normal B lymphocytes.
    Vogler LB; Glick AD; Collins RD
    Prog Clin Pathol; 1984; 9():197-223. PubMed ID: 6364223
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical patterns in B lymphoid malignancy.
    Galton DA; MacLennan IC
    Clin Haematol; 1982 Oct; 11(3):561-87. PubMed ID: 6756734
    [No Abstract]   [Full Text] [Related]  

  • 3. Two new monoclonal antibodies (LN-1, LN-2) reactive in B5 formalin-fixed, paraffin-embedded tissues with follicular center and mantle zone human B lymphocytes and derived tumors.
    Epstein AL; Marder RJ; Winter JN; Fox RI
    J Immunol; 1984 Aug; 133(2):1028-36. PubMed ID: 6376628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Volume regulation in leukemic and lymphoma cells in children and determination of cell lineage.
    Yumura K; Kawa-Ha K; Hara J; Franco EP; Ishihara S; Doi S; Yabuuchi H
    Jpn J Cancer Res; 1986 Apr; 77(4):392-8. PubMed ID: 3084429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphoma and leukemia of t-lymphocytes.
    Watanabe S; Shimosato Y; Shimoyama M
    Pathol Annu; 1981; 16(Pt 2):155-203. PubMed ID: 7036059
    [No Abstract]   [Full Text] [Related]  

  • 6. Lukes-Collins classification and its significance.
    Lukes RJ; Collins RD
    Cancer Treat Rep; 1977 Sep; 61(6):971-9. PubMed ID: 302740
    [No Abstract]   [Full Text] [Related]  

  • 7. Biological diagnosis of B-cell neoplasia.
    Lipford EH; Cossman J
    Cancer Invest; 1986; 4(1):69-80. PubMed ID: 3082471
    [No Abstract]   [Full Text] [Related]  

  • 8. Leukemic phase of non-Hodgkin's lymphomas. Hematological features and prognostic significance.
    Morra E; Lazzarino M; Orlandi E; Pagnucco G; Brusamolino E; Castello A; Inverardi D; Bernasconi C
    Haematologica; 1984; 69(1):15-29. PubMed ID: 6428991
    [No Abstract]   [Full Text] [Related]  

  • 9. Malignant lymphomas.
    Tindle BH
    Am J Pathol; 1984 Jul; 116(1):119-74. PubMed ID: 6377907
    [No Abstract]   [Full Text] [Related]  

  • 10. Malignancies of the immune system.
    Virella G; Goust JM
    Immunol Ser; 1993; 58():517-41. PubMed ID: 8424992
    [No Abstract]   [Full Text] [Related]  

  • 11. B & T markers in leukemia and lymphoma.
    Bloomfield CD
    Minn Med; 1979 Jul; 62(7):499-501. PubMed ID: 315029
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunohistochemical evaluation of hematologic malignancies.
    Miettinen M; Schwarting R; Hyun BH
    Hematol Oncol Clin North Am; 1994 Aug; 8(4):683-701. PubMed ID: 7961286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The usefulness of immunophenotypic and genotypic studies in the diagnosis and classification of hematopoietic and lymphoid neoplasms. An update.
    Frizzera G; Wu CD; Inghirami G
    Am J Clin Pathol; 1999 Jan; 111(1 Suppl 1):S13-39. PubMed ID: 9894467
    [No Abstract]   [Full Text] [Related]  

  • 14. An immunological classification of leukemias and hematosarcomas based on cell membrane markers with special reference to null cell disorders.
    Belpomme D; Lelarge N; Feuilhade de Chauvin F; Joseph R; Mathé G
    Recent Results Cancer Res; 1976; (56):98-110. PubMed ID: 1087447
    [No Abstract]   [Full Text] [Related]  

  • 15. The normal and malignant germinal centre.
    Stein H; Gerdes J; Mason DY
    Clin Haematol; 1982 Oct; 11(3):531-59. PubMed ID: 6756733
    [No Abstract]   [Full Text] [Related]  

  • 16. Cell marker analysis in hematopoietic neoplasias.
    Koziner B; Mertelsmann R; Siegal FP; Filippa DA
    Clin Bull; 1978; 8(2):47-53. PubMed ID: 359191
    [No Abstract]   [Full Text] [Related]  

  • 17. An immunological classification of leukemias and non Hodgkin's hematosarcomas based on T and B cell membrane markers with special reference to null "cell" disorders.
    Belpomme D; Lelarge N; Joseph R; Mathe G
    Eur J Cancer (1965); 1977; 13(4-5):311-9. PubMed ID: 326549
    [No Abstract]   [Full Text] [Related]  

  • 18. The binding of IgM aggregates to neoplastic B lymphocytes. II. Fc dependence and implications for a model of B lymphocyte differentiation.
    Rudders RA; Andersen J; Fried R
    J Immunol; 1980 May; 124(5):2347-51. PubMed ID: 6767785
    [No Abstract]   [Full Text] [Related]  

  • 19. B-cell malignancies and differentiation antigens defined with monoclonal antibodies.
    Kikuchi K; Koshiba H; Kasai K; Hiratsuka H; Fujimoto N; Uede T
    Jpn J Clin Oncol; 1983 Sep; 13(3):517-31. PubMed ID: 6417375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Surface markers and clinico-pathological characteristics of lymphoproliferative malignancies (author's transl)].
    Minato K; Shimoyama M
    Rinsho Byori; 1978; 26(3):194-200. PubMed ID: 306459
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.